Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / NVS - Is Alnylam Stock a Good Buy Now?


NVS - Is Alnylam Stock a Good Buy Now?

It took two solid decades for Alnylam (NASDAQ: ALNY) to carry its first new drug candidate across the finish line, but investors didn't need to wait long for the next one. The FDA approved the company's second drug just 16 months later, and the pace will probably accelerate. 

Interfering with the production of troublesome proteins is working for patients with gene-driven disorders. Can shares of Alnylam work for your portfolio?

Image source: Getty Images.

Continue reading

Stock Information

Company Name: Novartis AG
Stock Symbol: NVS
Market: NYSE
Website: novartis.com

Menu

NVS NVS Quote NVS Short NVS News NVS Articles NVS Message Board
Get NVS Alerts

News, Short Squeeze, Breakout and More Instantly...